A Study to Evaluate Treatment Satisfaction With Erenumab in Participants With Migraine
Clinical trial NCT04825678 · COMPLETED
Trial details
- NCT number
- NCT04825678
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-11
- Primary completion
- 2023-09-28
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.